Alessio Caccioppola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alessio Caccioppola has a total of 320 co-authors. Here are the top co-authors by number of shared publications:
Giacomo Grasselli
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
6 shared publicationsMauro Panigada
Fondazione IRCCS Policlinico San Matteo
5 shared publications- Giacomo Grasselli
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
4 shared publications - Andrea Meli
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
3 shared publications - Mauro Panigada
Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
3 shared publications - Vittorio Scaravilli
Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in Research Square
Point Of Care Evaluation of Fibrinolysis In Sepsis: The POCEFIS study
Purpose: Sepsis-induced coagulopathy (SIC) involves a complex imbalance between coagulation activation and fibrinolysis inhibition, contributing to microvascular thrombosis and organ dysfunction. Conventional coagulation tests inadequately capture functional fibrinolytic alterations. The POCEFIS study used the ClotPro® tissue plasminogen activator (TPA) test to characterize fibrinolysis in septic patients and evaluate its clinical relevance and temporal evolution during the early phase of sepsis. Methods: In a cohort of septic intensive care unit (ICU) patients, fibrinolysis was assessed using the ClotPro® TPA-test at enrollment and on day 1, 2, 3 and 7 after enrollment. Specific plasma biomarkers (PAI-1, plasminogen, protein C, and protein S) were analyzed at enrollment and on day 2 and 7. Septic patients were classified according to temporal evolution of fibrinolytic status during the first three days of observation (normal versus impaired fibrinolysis). Results: At enrollment, impaired fibrinolysis was present in 38% of septic patients. However, considering the first three ICU days, 66% of patients exhibited fibrinolysis impairment. Impaired fibrinolysis was associated with higher lactate (4.2 mmol/L vs 2.9 mmol/L, p=0.0482), INR (1.5 vs 1.2, p=0.0156), and SOFA score (10.9 vs. 9.4, p=0.0282) at enrollment. Patients with impaired fibrinolysis showed persistently higher C-reactive protein and D-dimer values during the first week of observation (linear mixed-effects model, group effect p=0.0047 and p=0.0201). Conclusions: Fibrinolysis impairment is frequent, dynamic, and clinically relevant in sepsis. The ClotPro® TPA-test provides a global point-of-care evaluation of fibrinolysis. Serial viscoelastic assessment may improve risk stratification and support the development of individualized therapeutic strategies targeting SIC.
- 10 November 2026
- Published by Springer Nature in Research Square
Open AccessPoint Of Care Evaluation of Fibrinolysis In Sepsis: The POCEFIS study
Purpose: Sepsis-induced coagulopathy (SIC) involves a complex imbalance between coagulation activation and fibrinolysis inhibition, contributing to microvascular thrombosis and organ dysfunction. Conventional coagulation tests inadequately capture functional fibrinolytic alterations. The POCEFIS study used the ClotPro® tissue plasminogen activator (TPA) test to characterize fibrinolysis in septic patients and evaluate its clinical relevance and temporal evolution during the early phase of sepsis. Methods: In a cohort of septic intensive care unit (ICU) patients, fibrinolysis was assessed using the ClotPro® TPA-test at enrollment and on day 1, 2, 3 and 7 after enrollment. Specific plasma biomarkers (PAI-1, plasminogen, protein C, and protein S) were analyzed at enrollment and on day 2 and 7. Septic patients were classified according to temporal evolution of fibrinolytic status during the first three days of observation (normal versus impaired fibrinolysis). Results: At enrollment, impaired fibrinolysis was present in 38% of septic patients. However, considering the first three ICU days, 66% of patients exhibited fibrinolysis impairment. Impaired fibrinolysis was associated with higher lactate (4.2 mmol/L vs 2.9 mmol/L, p=0.0482), INR (1.5 vs 1.2, p=0.0156), and SOFA score (10.9 vs. 9.4, p=0.0282) at enrollment. Patients with impaired fibrinolysis showed persistently higher C-reactive protein and D-dimer values during the first week of observation (linear mixed-effects model, group effect p=0.0047 and p=0.0201). Conclusions: Fibrinolysis impairment is frequent, dynamic, and clinically relevant in sepsis. The ClotPro® TPA-test provides a global point-of-care evaluation of fibrinolysis. Serial viscoelastic assessment may improve risk stratification and support the development of individualized therapeutic strategies targeting SIC.
- Open Access
- 15 May 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1)
Definition and prognostic value of response to prone positioning in ARDS: a systematic review and meta-analysis
Prone positioning improves survival in patients with ARDS; however, no consensus exists on how to define a positive response to this intervention. We condu
- 15 May 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1)
Open AccessDefinition and prognostic value of response to prone positioning in ARDS: a systematic review and meta-analysis
Prone positioning improves survival in patients with ARDS; however, no consensus exists on how to define a positive response to this intervention. We condu
- Open Access
- 27 January 2026
- Published by BMJ in BMJ Open Quality
- Vol. 15 (1) , e003760
Cultural transformation beyond checklists for patient safety: a longitudinal evaluation of safety interventions in critical care
Background: Implementing structured safety interventions in intensive care units (ICUs) remains challenging due to patient complexity, staff turnover and dynamic workflows. This study evaluates the longitudinal impact of a multidisciplinary safety improvement programme in a high-acuity ICU. Methods: A 2-year prospective evaluation was conducted in a 12-bed academic ICU in Milan, Italy. The Hospital Survey on Patient Safety Culture was administered to all ICU professionals (physicians, nurses, physiotherapists) in December 2022 and repeated in December 2024. Interventions included staff training, enhanced event reporting systems, regular morbidity and mortality conferences and a multidisciplinary safety team. Responses were analysed descriptively, including subgroup analysis by professional category and staff turnover. Results: A total of 86 staff completed the 2022 survey, and 66 completed the 2024 survey, with 56 participating in both. Over the 2 years, perceptions of teamwork (68%–81%), communication openness (47%–60%) and comfort in reporting errors (38%–55%) showed substantial improvement. The proportion of staff who perceived management support for safety increased from 70%–80%. Staff hired after 2022 reported more favourable safety perceptions than continuing staff, particularly in communication and reporting domains. Conclusions: Structured, multidisciplinary interventions led to measurable improvements in ICU safety culture. However, persistent interprofessional differences and under-reporting of adverse events highlight the need for targeted strategies. Safety culture transformation requires sustained leadership, continuous onboarding and system-focused feedback mechanisms to ensure long-term impact.
- 27 January 2026
- Published by BMJ in BMJ Open Quality
- Vol. 15 (1) , e003760
Open AccessCultural transformation beyond checklists for patient safety: a longitudinal evaluation of safety interventions in critical care
Background: Implementing structured safety interventions in intensive care units (ICUs) remains challenging due to patient complexity, staff turnover and dynamic workflows. This study evaluates the longitudinal impact of a multidisciplinary safety improvement programme in a high-acuity ICU. Methods: A 2-year prospective evaluation was conducted in a 12-bed academic ICU in Milan, Italy. The Hospital Survey on Patient Safety Culture was administered to all ICU professionals (physicians, nurses, physiotherapists) in December 2022 and repeated in December 2024. Interventions included staff training, enhanced event reporting systems, regular morbidity and mortality conferences and a multidisciplinary safety team. Responses were analysed descriptively, including subgroup analysis by professional category and staff turnover. Results: A total of 86 staff completed the 2022 survey, and 66 completed the 2024 survey, with 56 participating in both. Over the 2 years, perceptions of teamwork (68%–81%), communication openness (47%–60%) and comfort in reporting errors (38%–55%) showed substantial improvement. The proportion of staff who perceived management support for safety increased from 70%–80%. Staff hired after 2022 reported more favourable safety perceptions than continuing staff, particularly in communication and reporting domains. Conclusions: Structured, multidisciplinary interventions led to measurable improvements in ICU safety culture. However, persistent interprofessional differences and under-reporting of adverse events highlight the need for targeted strategies. Safety culture transformation requires sustained leadership, continuous onboarding and system-focused feedback mechanisms to ensure long-term impact.
- 22 December 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (3) , e51
Reply to Letter to the Editor: High-Caliber Femoral Dual-Lumen Cannula for ECCO2R in Hypercapnic Respiratory Failure: Efficacy and Safety Evaluation
- 22 December 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (3) , e51
Reply to Letter to the Editor: High-Caliber Femoral Dual-Lumen Cannula for ECCO2R in Hypercapnic Respiratory Failure: Efficacy and Safety Evaluation
- Open Access
- 7 November 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (3) , 255-262
High-Caliber Femoral Dual-Lumen Cannula for ECCO2R in Hypercapnic Respiratory Failure: Efficacy and Safety Evaluation
Extracorporeal carbon dioxide removal (ECCO₂R) prevents intubation and facilitates extubation in patients with hypercapnic respiratory failure. However, low-flow systems increase shear stress and need full anticoagulation, increasing the risk of circuit-related complications. We assessed the safety and efficacy of a high-caliber dual-lumen cannula, designed for jugular veno-venous extracorporeal membrane oxygenation (VV ECMO), repurposed for femoral vein insertion, with the aim of achieving higher blood-flow rates and more efficient CO₂ clearance. We retrospectively analyzed 16 intensive care unit (ICU) patients (62 years; 81% chronic obstructive pulmonary disease [COPD]) treated with ECCO₂R using a large-caliber dual-lumen cannula (20–23 Fr) inserted via the femoral vein. Key outcomes included changes in gas exchange, ventilatory support status, and complications. Extracorporeal carbon dioxide removal enabled rapid CO₂ clearance, with arterial carbon dioxide pressure (PaCO₂) decreasing from 68 [62–95] to 49 [45–56] mm Hg at 2 h, and pH increasing from 7.20 [7.16–7.27] to 7.36 [7.33–7.41]. Fifty-six percent of patients avoided intubation, whereas all intubated patients were extubated during ECCO₂R. The median support duration was 5 [4–7] days. No hemolysis was documented. One bleeding episode and one clotting event occurred; no thrombotic or cannulation-related complications were observed. Femoral vein cannulation with a large-caliber dual-lumen cannula for ECCO₂R appears feasible and safe. This strategy may offer technical and clinical advantages over conventional ECCO₂R systems, warranting prospective investigation.
- 7 November 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (3) , 255-262
Open AccessHigh-Caliber Femoral Dual-Lumen Cannula for ECCO2R in Hypercapnic Respiratory Failure: Efficacy and Safety Evaluation
Extracorporeal carbon dioxide removal (ECCO₂R) prevents intubation and facilitates extubation in patients with hypercapnic respiratory failure. However, low-flow systems increase shear stress and need full anticoagulation, increasing the risk of circuit-related complications. We assessed the safety and efficacy of a high-caliber dual-lumen cannula, designed for jugular veno-venous extracorporeal membrane oxygenation (VV ECMO), repurposed for femoral vein insertion, with the aim of achieving higher blood-flow rates and more efficient CO₂ clearance. We retrospectively analyzed 16 intensive care unit (ICU) patients (62 years; 81% chronic obstructive pulmonary disease [COPD]) treated with ECCO₂R using a large-caliber dual-lumen cannula (20–23 Fr) inserted via the femoral vein. Key outcomes included changes in gas exchange, ventilatory support status, and complications. Extracorporeal carbon dioxide removal enabled rapid CO₂ clearance, with arterial carbon dioxide pressure (PaCO₂) decreasing from 68 [62–95] to 49 [45–56] mm Hg at 2 h, and pH increasing from 7.20 [7.16–7.27] to 7.36 [7.33–7.41]. Fifty-six percent of patients avoided intubation, whereas all intubated patients were extubated during ECCO₂R. The median support duration was 5 [4–7] days. No hemolysis was documented. One bleeding episode and one clotting event occurred; no thrombotic or cannulation-related complications were observed. Femoral vein cannulation with a large-caliber dual-lumen cannula for ECCO₂R appears feasible and safe. This strategy may offer technical and clinical advantages over conventional ECCO₂R systems, warranting prospective investigation.
- Open Access
- 9 August 2025
- Published by SAGE Publications in Perfusion
- Vol. 41 (4) , 444-454
Prone positioning and bleeding risk during extracorporeal membrane oxygenation in severe ARDS patients
Purpose: To assess whether prone positioning (PP) increases bleeding risk compared to supine positioning in ARDS patients undergoing veno venous Extracorporeal Membrane Oxygenation (VV ECMO). Materials and Methods: A single-center retrospective observational study was conducted between January 2012 and March 2023. Data were systematically collected from an institutional ECMO registry, including baseline characteristics, daily variables, bleeding events, and outcomes. We compared the relative risk (RR) and incidence rate ratio (IRR) of bleeding between ‘Prone' and ‘Supine' patients. Bleeding-free days were analyzed using Kaplan-Meier curves and the Log-Rank test. Results: We included 136 consecutive severe ARDS patients undergoing VV ECMO (65% male, age 52 ± 11, 53% bacterial pneumonia), with 85 (62%) and 51 (38%) in the ‘Prone’ and ‘Supine’ group respectively. Bleeding occurred in 79 (58%) patients, with 43 of these being major bleeding events, including 14 intracranial hemorrhages. Fifty-two (61%) ‘Prone’ patients versus 27 (53%) ‘Supine’ patients had bleeding (RR 1.11 (95% CI: 0.81–1.52), p = .44; IRR 1.08 (95% CI: 0.68–1.75), p = .75), with a tendency towards lower major bleeding incidence in the ‘Prone’ versus ‘Supine’ patients (IRR 0.54 (95% CI: 0.29–1.03), p = .06). Kaplan-Meier survival analysis showed no significant difference in bleeding-free days between the ‘Prone’ and ‘Supine’ groups ( p = .11). Conclusions: PP during VV ECMO for ARDS was not associated with an increased incidence of bleeding. Further prospective studies are warranted to confirm these findings.
- 9 August 2025
- Published by SAGE Publications in Perfusion
- Vol. 41 (4) , 444-454
Open AccessProne positioning and bleeding risk during extracorporeal membrane oxygenation in severe ARDS patients
Purpose: To assess whether prone positioning (PP) increases bleeding risk compared to supine positioning in ARDS patients undergoing veno venous Extracorporeal Membrane Oxygenation (VV ECMO). Materials and Methods: A single-center retrospective observational study was conducted between January 2012 and March 2023. Data were systematically collected from an institutional ECMO registry, including baseline characteristics, daily variables, bleeding events, and outcomes. We compared the relative risk (RR) and incidence rate ratio (IRR) of bleeding between ‘Prone' and ‘Supine' patients. Bleeding-free days were analyzed using Kaplan-Meier curves and the Log-Rank test. Results: We included 136 consecutive severe ARDS patients undergoing VV ECMO (65% male, age 52 ± 11, 53% bacterial pneumonia), with 85 (62%) and 51 (38%) in the ‘Prone’ and ‘Supine’ group respectively. Bleeding occurred in 79 (58%) patients, with 43 of these being major bleeding events, including 14 intracranial hemorrhages. Fifty-two (61%) ‘Prone’ patients versus 27 (53%) ‘Supine’ patients had bleeding (RR 1.11 (95% CI: 0.81–1.52), p = .44; IRR 1.08 (95% CI: 0.68–1.75), p = .75), with a tendency towards lower major bleeding incidence in the ‘Prone’ versus ‘Supine’ patients (IRR 0.54 (95% CI: 0.29–1.03), p = .06). Kaplan-Meier survival analysis showed no significant difference in bleeding-free days between the ‘Prone’ and ‘Supine’ groups ( p = .11). Conclusions: PP during VV ECMO for ARDS was not associated with an increased incidence of bleeding. Further prospective studies are warranted to confirm these findings.
- 5 May 2025
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 52 (04) , 405-416
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications
Sepsis is a complex syndrome characterized by physiological, pathological, and biochemical abnormalities induced by infection, with up to 70% of patients experiencing coagulation alterations, ranging from subclinical coagulopathy to disseminated intravascular coagulation (DIC). The multifactorial nature of sepsis-related coagulopathy and the limitations of standard diagnostic parameters, such as platelet count and traditional coagulation tests, complicate its definition and management. Assessing coagulopathy related to sepsis presents significant challenges due to current definitions primarily focusing on diagnosing advanced stages of coagulation dysfunction, thereby overlooking the dynamic and evolving nature of the condition. Viscoelastic hemostatic assays (VHAs) have emerged as valuable tools in this context, offering real-time insights into clot formation, stabilization, and lysis by integrating both plasma and cellular contributions to coagulation. Data from clinical studies suggest that early stages of sepsis coagulopathy are characterized by hypercoagulability, while advanced stages may lead to hypocoagulability and DIC. Moreover, specific point-of-care assays can evaluate platelet performance in the clotting mechanism and potentially help the diagnosis of platelet dysfunction in sepsis. Additionally, the phenomenon of fibrinolysis inhibition contributes to the persistence of fibrin clots, promoting tissue ischemia and multiorgan dysfunction. Modified VHAs appear promising for detecting fibrinolysis impairment, which is associated with poorer outcomes, but the standardization of results is still a work in progress. Incorporating VHAs data into treatment strategies could lead to more targeted therapies, potentially improving outcomes in septic patients by addressing both hypercoagulable and hypocoagulable states, as well as fibrinolysis abnormalities. * These authors contributed equally to this article. Article published online: 24 May 2025 © 2025. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 5 May 2025
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 52 (04) , 405-416
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications
Sepsis is a complex syndrome characterized by physiological, pathological, and biochemical abnormalities induced by infection, with up to 70% of patients experiencing coagulation alterations, ranging from subclinical coagulopathy to disseminated intravascular coagulation (DIC). The multifactorial nature of sepsis-related coagulopathy and the limitations of standard diagnostic parameters, such as platelet count and traditional coagulation tests, complicate its definition and management. Assessing coagulopathy related to sepsis presents significant challenges due to current definitions primarily focusing on diagnosing advanced stages of coagulation dysfunction, thereby overlooking the dynamic and evolving nature of the condition. Viscoelastic hemostatic assays (VHAs) have emerged as valuable tools in this context, offering real-time insights into clot formation, stabilization, and lysis by integrating both plasma and cellular contributions to coagulation. Data from clinical studies suggest that early stages of sepsis coagulopathy are characterized by hypercoagulability, while advanced stages may lead to hypocoagulability and DIC. Moreover, specific point-of-care assays can evaluate platelet performance in the clotting mechanism and potentially help the diagnosis of platelet dysfunction in sepsis. Additionally, the phenomenon of fibrinolysis inhibition contributes to the persistence of fibrin clots, promoting tissue ischemia and multiorgan dysfunction. Modified VHAs appear promising for detecting fibrinolysis impairment, which is associated with poorer outcomes, but the standardization of results is still a work in progress. Incorporating VHAs data into treatment strategies could lead to more targeted therapies, potentially improving outcomes in septic patients by addressing both hypercoagulable and hypocoagulable states, as well as fibrinolysis abnormalities. * These authors contributed equally to this article. Article published online: 24 May 2025 © 2025. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- Open Access
- 10 October 2024
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 17 (1) , 1-4
Shark fin ECG pattern in a patient with acute ascending aortic dissection
The ‘shark-fin’ ECG-sign is a rare electrocardiographic pattern seen in ACS, typically associated with poor prognosis. However, its manifestation in acute aortic syndromes remains largely unexplored. Here, we present a case of a patient diagnosed with Ascending Aortic Dissection, who presented to ED with acute chest pain and shark-fin ECG-pattern.
- 10 October 2024
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 17 (1) , 1-4
Open AccessShark fin ECG pattern in a patient with acute ascending aortic dissection
The ‘shark-fin’ ECG-sign is a rare electrocardiographic pattern seen in ACS, typically associated with poor prognosis. However, its manifestation in acute aortic syndromes remains largely unexplored. Here, we present a case of a patient diagnosed with Ascending Aortic Dissection, who presented to ED with acute chest pain and shark-fin ECG-pattern.
- Open Access
- 5 May 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (3) , 787-788
Cause-specific mortality during ECMO: A call for a standardized definition?
- 5 May 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (3) , 787-788
Open AccessCause-specific mortality during ECMO: A call for a standardized definition?
- 23 April 2024
- Published by SAGE Publications in Perfusion
- Vol. 39 (1_suppl) , 77S-80S
Agreement between the thromboelastography reaction time parameter using fresh and citrated whole blood during extracorporeal membrane oxygenation with Teg®5000 and Teg®6s
Purpose: We aimed at assessing the correlation between TEG reaction time (TEG-R) in citrated and fresh blood samples with TEG5000 and TEG 6S during heparin administration in patients with and without ECMO support. Materials and Methods: Paired TEG5000 (fresh and citrated whole blood, kaolin and kaolin-heparinase) and TEG6S (citrated whole blood) samples were obtained, together with standard coagulation laboratory tests. Bland-Altman analysis and Lin's concordance correlation coefficient were used to assess agreement. Results: Thirteen consecutive ECMO patients and eight consecutive non-ECMO patients were enrolled and TEG was performed for a total of 84 paired samples. ECMO patients received 19.2 (12.6-25.8) U/kg/h of heparin. Five of the non-ECMO patients did not receive heparin, two of them received a very low prophylactic dose (1.6 and 2.9 IU/kg/h, respectively), and one of them 13.1 U/kg/h of heparin. Using TEG®5000, TEG-R was 21.0 (−23.4; 65.5) min longer on fresh compared to citrated blood in patients receiving heparin while only 1.58 (−5.5; 8.7) min longer in patients not-receiving heparin. These differences were reverted by heparinase. Conclusions: Using citrated-recalcified blood to perform TEG might lead to underestimation of the effect of heparin.
- 23 April 2024
- Published by SAGE Publications in Perfusion
- Vol. 39 (1_suppl) , 77S-80S
Agreement between the thromboelastography reaction time parameter using fresh and citrated whole blood during extracorporeal membrane oxygenation with Teg®5000 and Teg®6s
Purpose: We aimed at assessing the correlation between TEG reaction time (TEG-R) in citrated and fresh blood samples with TEG5000 and TEG 6S during heparin administration in patients with and without ECMO support. Materials and Methods: Paired TEG5000 (fresh and citrated whole blood, kaolin and kaolin-heparinase) and TEG6S (citrated whole blood) samples were obtained, together with standard coagulation laboratory tests. Bland-Altman analysis and Lin's concordance correlation coefficient were used to assess agreement. Results: Thirteen consecutive ECMO patients and eight consecutive non-ECMO patients were enrolled and TEG was performed for a total of 84 paired samples. ECMO patients received 19.2 (12.6-25.8) U/kg/h of heparin. Five of the non-ECMO patients did not receive heparin, two of them received a very low prophylactic dose (1.6 and 2.9 IU/kg/h, respectively), and one of them 13.1 U/kg/h of heparin. Using TEG®5000, TEG-R was 21.0 (−23.4; 65.5) min longer on fresh compared to citrated blood in patients receiving heparin while only 1.58 (−5.5; 8.7) min longer in patients not-receiving heparin. These differences were reverted by heparinase. Conclusions: Using citrated-recalcified blood to perform TEG might lead to underestimation of the effect of heparin.